Drs. Miriam Merad and Padmanee Sharma will be honored with the 2018 William B. Coley Award, while Dr. Boris Reizis will receive the Frederick W. Alt Award
The Cancer Research Institute announced that it will honor biotechnology company Regeneron, and journalist and filmmaker Perri Peltz with the 2018 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.
FNIH has selected CRI to be its source of landscape intelligence in immuno-oncology.
Ludwig Cancer Research and the Cancer Research Institute (CRI) announce the initiation of a clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI® (durvalumab) for advanced ovarian and colorectal cancers.
A comprehensive, neutral analysis of the global cancer cell therapy landscape; 753 cancer cell therapies in the global development pipeline, with 375 in clinical studies
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
CRI scientists Dr. Michele Ardolino and Dr. David Raulet showed that Natural Killer cells can help eliminate tumors after checkpoint immunotherapy treatment even in the absence of T cells.
The third installment of the Rational Combinations 360 conference, which will be held in Philadelphia September 13-14, seeks to improve the design and application of combination immunotherapies for patients